Overview
Glaucoma-ectopia lentis-microspherophakia-stiff joints-short stature syndrome (also known as Weill-Marchesani syndrome or WMS) is a rare connective tissue disorder that affects multiple body systems, most notably the eyes, skeleton, and joints. The condition is characterized by short stature, brachydactyly (short fingers), joint stiffness with limited range of motion, and distinctive eye abnormalities including microspherophakia (abnormally small and spherical lens), ectopia lentis (displacement of the lens), and glaucoma. The small, round lens can cause severe myopia (nearsightedness) and may block the flow of fluid within the eye, leading to acute or chronic glaucoma that can threaten vision if untreated. Affected individuals typically have a stocky, muscular build with proportionate short stature and may also exhibit thickened skin. Weill-Marchesani syndrome can be inherited in either an autosomal recessive or autosomal dominant pattern, depending on the causative gene. Autosomal recessive forms have been linked to mutations in the ADAMTS10 and LTBP2 genes, while autosomal dominant forms are associated with mutations in FBN1 (fibrillin-1). These genes are involved in the structure and regulation of extracellular matrix components and transforming growth factor-beta (TGF-β) signaling, which are critical for normal connective tissue development. Onset of clinical features is typically recognized in childhood, though some manifestations may be present from birth. There is no cure for Weill-Marchesani syndrome, and management is primarily supportive and symptom-directed. Ophthalmologic care is essential and may include medications to manage glaucoma (such as miotics or other intraocular pressure-lowering agents), corrective lenses for refractive errors, and surgical intervention for lens subluxation or glaucoma that does not respond to medical therapy. Regular monitoring by an ophthalmologist is critical to prevent vision loss. Orthopedic and physical therapy evaluations may help manage joint stiffness, and growth should be monitored throughout childhood.
Also known as:
Clinical phenotype terms— hover any for plain English:
Variable
Can be inherited in different ways depending on the underlying gene
Childhood
Begins in childhood, roughly ages 1 to 12
Treatments
No FDA-approved treatments are currently listed for Glaucoma-ectopia lentis-microspherophakia-stiff joints-short stature syndrome.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Glaucoma-ectopia lentis-microspherophakia-stiff joints-short stature syndrome at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Glaucoma-ectopia lentis-microspherophakia-stiff joints-short stature syndrome.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Glaucoma-ectopia lentis-microspherophakia-stiff joints-short stature syndrome.
Community
No community posts yet. Be the first to share your experience with Glaucoma-ectopia lentis-microspherophakia-stiff joints-short stature syndrome.
Start the conversation →Latest news about Glaucoma-ectopia lentis-microspherophakia-stiff joints-short stature syndrome
No recent news articles for Glaucoma-ectopia lentis-microspherophakia-stiff joints-short stature syndrome.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Glaucoma-ectopia lentis-microspherophakia-stiff joints-short stature syndrome
What is Glaucoma-ectopia lentis-microspherophakia-stiff joints-short stature syndrome?
Glaucoma-ectopia lentis-microspherophakia-stiff joints-short stature syndrome (also known as Weill-Marchesani syndrome or WMS) is a rare connective tissue disorder that affects multiple body systems, most notably the eyes, skeleton, and joints. The condition is characterized by short stature, brachydactyly (short fingers), joint stiffness with limited range of motion, and distinctive eye abnormalities including microspherophakia (abnormally small and spherical lens), ectopia lentis (displacement of the lens), and glaucoma. The small, round lens can cause severe myopia (nearsightedness) and may
At what age does Glaucoma-ectopia lentis-microspherophakia-stiff joints-short stature syndrome typically begin?
Typical onset of Glaucoma-ectopia lentis-microspherophakia-stiff joints-short stature syndrome is childhood. Age of onset can vary across affected individuals.